Clinical Trial Update: A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating two doses of PRAX-944 in participants with essential tremor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• PRAX-944 (PRAX-944)

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED